Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 138

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 138
---
21.1   | Subsidiaries of Biodexa Pharmaceuticals PLC (incorporated by reference to Exhibit 8.1 of the Company’s Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC on April 11, 2025).                                                                              |
| 23.1*  | Consent of PKF Littlejohn LLP, independent registered public accounting firm.                                                                                                                                                                                                               |
| 23.2*  | Consent of Forvis Mazars LLP, independent registered public accounting firm.                                                                                                                                                                                                                |
| 23.3   | Consent of Brown Rudnick (included in Exhibit 5.1).                                                                                                                                                                                                                                         |
| 24.1   | Powers of Attorney (included on signature page).                                                                                                                                                                                                                                            |

| II-9 |

__

* Filed herewith.

| 

# | Management contract or compensatory plan or arrangement. |
| † | Certain portions of this exhibit (indicated by asterisks) have been omitted because they are not material 
 and would likely cause competitive harm to Biodexa Pharmaceuticals PLC if publicly disclosed.             |

<div align='center'>II-10</div>